This guide is educational and is being prepared for medical review. It is not medical advice.
Autoimmune diseases — such as rheumatoid arthritis, lupus, multiple sclerosis, and scleroderma — occur when the immune system attacks the body’s own tissues. Regenerative and cell-based approaches are a real area of study here, and it helps to separate legitimate, oversight-backed therapy from clinic marketing.
Modern rheumatology and immunology care has transformed outcomes for many autoimmune conditions. Disease-modifying and biologic medications can control inflammation, slow progression, and protect organs and joints. Early diagnosis and consistent specialist care remain the foundation, and for many people they make an enormous difference.
There is serious science here — but it needs to be described precisely. Hematopoietic stem cell transplantation (HSCT) is an established, intensive therapy used in specialized centers and clinical trials for selected patients with severe multiple sclerosis or scleroderma; it is a rigorous medical procedure, not a spa injection. Separately, mesenchymal stem cell (MSC) infusions are being studied for several autoimmune conditions, but the evidence is still early and no MSC therapy is FDA-approved for these diseases. Be careful not to confuse marketed MSC “infusions” with legitimate HSCT programs.
To explore the real research, search registered studies at ClinicalTrials.gov.
The FDA has warned about clinics selling unapproved stem cell products. Approach large cash-pay “immune reset” or “stem cell” packages with caution, especially abroad. Read: FDA Consumer Alert on Regenerative Medicine.
Use the provider listings below to find clinics and specialists, ask about the specific evidence for any therapy offered, and coordinate with your rheumatologist or specialist.
